Veterinary Vaccines Market to Reach USD 14.5 Billion by 2032 | SNS Insider

The Veterinary Vaccines market increasing focus on animal health, rising prevalence of zoonotic diseases, and demand for safe livestock and pet care globally.

AUSTIN, TX, UNITED STATES, December 20, 2024 /EINPresswire.com/ --
The Veterinary Vaccines Market size was valued at USD 8.5 billion in 2023 and is projected to reach USD 14.5 billion by 2032, growing at a CAGR of 6% over the forecast period 2024-2032.

Veterinary Vaccines Market Overview

The Veterinary Vaccines Market is witnessing robust growth, driven by increasing concerns for animal health and welfare and rising demand for safe and high-quality animal-derived food products. The expanding global population and heightened awareness of zoonotic diseases have fueled the demand for effective vaccines.

On the supply side, the market benefits from technological advancements such as DNA and mRNA vaccines, which have revolutionized vaccine development. Major players are increasingly investing in research and development to enhance vaccine efficacy and address new disease challenges.

Additionally, the growing pet ownership trend has accelerated demand for companion animal vaccines, while the livestock sector drives the need for vaccines that ensure animal productivity and food safety. The market is also supported by government initiatives and private-sector collaborations, aiming to curb zoonotic disease outbreaks through widespread vaccination campaigns.

Get a Sample Report of Veterinary Vaccines Market@ https://www.snsinsider.com/sample-request/4555

Key Players Listed in Veterinary Vaccines Market Are:

•Zoetis Inc.
•Boehringer Ingelheim
•Merck Animal Health
•Elanco Animal Health
•Ceva Santé Animale
•Virbac
•Phibro Animal Health Corporation
•Vetoquinol
•HIPRA
•Biogenesis Bago
•Neogen Corporation
•Idexx Laboratories
•Indian Immunologicals Ltd.
•Hester Biosciences
•Dechra Pharmaceuticals

Segment Analysis

By Type

Live attenuated vaccines dominated the Veterinary Vaccines Market in 2023, accounting for a 40.0% share. These vaccines are highly effective in providing long-term immunity and are widely used to prevent critical diseases such as rabies, distemper, and parvovirus. Their ability to elicit a robust and durable immune response, combined with their cost-effectiveness, has established them as a preferred choice among veterinarians and livestock owners.

Meanwhile, DNA and mRNA vaccines are emerging as the fastest-growing segment, projected to grow at an impressive CAGR of 8% between 2024 and 2032. These advanced vaccines enable rapid development and customization to address emerging and complex diseases. Their adaptability and potential to combat novel pathogens position them as transformative solutions in veterinary medicine.

By Application

Vaccines for companion animals, including dogs, cats, and horses, constituted 45.0% of the Veterinary Vaccines Market in 2023. This segment's growth is fueled by the rising trend of pet ownership globally, as pets are increasingly regarded as family members. Enhanced awareness of pet health and welfare, coupled with rising expenditures on veterinary care, has driven significant demand for vaccines against diseases such as rabies, distemper, and feline leukemia.

Simultaneously, the livestock segment is experiencing robust growth, with a projected CAGR of 7%. This surge is attributed to heightened demand for vaccines targeting critical diseases like foot-and-mouth disease, avian influenza, and swine fever. The focus on ensuring food safety, improving animal productivity, and mitigating economic losses in agriculture has further underscored the importance of livestock vaccination.

Do you have any specific queries or need customization research on Veterinary Vaccines Market, Enquire Now@ https://www.snsinsider.com/enquiry/4555

Key Market Segmentation:

By Type:

•Live Attenuated Vaccines
•Inactivated Vaccines
•Subunit, Recombinant, and Conjugate Vaccines
•DNA and mRNA Vaccines

By Application:

•Companion Animals
•Livestock
•Wildlife

Regional Analysis

North America dominated the Veterinary Vaccines Market in 2023, holding a 38% share. This leadership is attributed to advanced veterinary infrastructure, significant investments in research and development, and a strong focus on animal health. The region's robust adoption of innovative vaccine technologies further bolsters its position in the market.

In contrast, the Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of 8% during the forecast period. This growth is driven by increasing livestock populations, rising disposable incomes, and growing awareness of zoonotic diseases. Countries such as China and India are at the forefront of this expansion, supported by their large agricultural base and government initiatives promoting animal health. The region's dynamic market presents lucrative opportunities for vaccine manufacturers targeting both companion animals and livestock.

Buy Now Enterprise-User PDF of Veterinary Vaccines Market@ https://www.snsinsider.com/checkout/4555

Recent Developments

May 2024: MSD Animal Health, a division of Merck & Co., Inc., received marketing authorization from the European Commission for INNOVAX-ND-H5, a vaccine specifically designed for chickens to combat Newcastle disease and avian influenza.
June 2024: At the World Buiatrics Congress in Mexico, HIPRA launched the DIVENCE vaccine range, targeting viral diseases in cattle. These vaccines aim to enhance productivity and disease resistance.
August 2024: Zoetis introduced "ProPulse," a revolutionary DNA vaccine platform designed to accelerate the development of veterinary vaccines for emerging diseases, particularly in livestock.
September 2024: Boehringer Ingelheim announced the release of "PetCure" vaccines, tailored for companion animals, focusing on emerging pathogens and zoonotic diseases.
October 2024: Ceva Santé Animale launched its new vaccine line for swine health, emphasizing solutions for African swine fever and other critical diseases in the livestock sector.
November 2024: Elanco Animal Health unveiled an advanced mRNA vaccine platform to address challenges in poultry health, with a focus on avian influenza and salmonella prevention.
The Veterinary Vaccines Market is on a growth trajectory, driven by advancements in vaccine technologies and the increasing demand for comprehensive animal healthcare solutions. Innovations such as DNA and mRNA vaccine platforms are reshaping the industry, enabling faster development and more targeted disease prevention. These technological strides address the growing need for solutions to combat emerging zoonotic diseases and enhance livestock productivity.

Key players in the market are actively expanding their product portfolios to cater to diverse applications, ranging from companion animal care to livestock health management. Focused investments in research and development, along with strategic collaborations, are ensuring the availability of cutting-edge vaccines. These efforts not only support global animal health but also contribute to food security and sustainable veterinary practices.

Table of Content

1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Veterinary Vaccines Market Segmentation, By Type
8. Veterinary Vaccines Market Segmentation, By Application
9. Regional Analysis
10. Company Profile
11. Use Cases and Best Practices
12. Conclusion

Need More Insights on Veterinary Vaccines Market, Request an Analyst Call@ https://www.snsinsider.com/request-analyst/4555

About Us:

SNS Insider stands out as a distinguished market research and insights firm, boasting numerous accolades and a sterling reputation for excellence in service and strategy. Serving as your strategic ally, we specialize in reshaping challenges and uncovering solutions to even the most complex business dilemmas. Harnessing the power of expertise and interpersonal connections, we drive profound consumer insights and elevate client experiences. When you engage our services, you embark on a journey with seasoned and adept professionals. We prioritize collaboration with our clients, recognizing the paramount importance of tailoring each project to their unique requirements. After all, nobody comprehends your customers or community better than you do. Hence, our team adeptly crafts the right inquiries that resonate with your audience, ensuring the collection of unparalleled information.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US)

Akash Anand
SNS Insider Pvt. Ltd
415-230-0044
info@snsinsider.com
Visit us on social media:
Facebook
X
LinkedIn
Instagram